NCT01476072View on ClinicalTrials.gov

31P MRS Ischaemic Exercise Optimisation and COPD

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Atrophy, Muscular
Interventions
OTHER

MRI scan

MRI scan only, methodology study with no other intervention

Trial Locations (1)

W12 ONN

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01476072 - 31P MRS Ischaemic Exercise Optimisation and COPD | Biotech Hunter | Biotech Hunter